Polymorphisms of the human NRAMP1 gene are associated with response to bacillus Calmette-Guerin immunotherapy for superficial bladder cancer

Journal of Urology

Volumn 175, Issue 4, 2006, Pages 1506-1511

  Decobert, Marc ^b   LaRue, Hélène ^b   Bergeron, Alain ^b   Harel, François ^b   Pfister, Christian ^b   Rousseau, François ^a   Lacombe, Louis ^b   Fradet, Yves ^a  

^a LAVAL UNIVERSITY   (Canada)

^b L'Hôtel Dieu de Québec ^*

Author keywords

Bladder; Bladder neoplasms; Gene expression; Immunotherapy; Mycobacterium bovis

Indexed keywords

BCG VACCINE; DNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1;

ARTICLE; BLADDER CANCER; BLADDER TUMOR; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SURVIVAL; TRANSURETHRAL RESECTION; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; BCG VACCINE; CATION TRANSPORT PROTEINS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; POLYMORPHISM, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 33644603499     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)00653-1     Document Type: Article

References (20)

1. H.W. Herr Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors 15-year outcome J Urol 163 2000 60
2. A.B. Alexandroff, A.M. Jackson, M.A. O'Donnell, K. James BCG immunotherapy of bladder cancer 20 years on Lancet 353: 1999 1689
3. H.W. Herr, G. Jakse, J. Sheinfeld The T1 bladder tumor Semin Urol 8 1990 254
4. L.R. Kavoussi, R.J. Torrence, D.P. Gillen, M.A. Hudson, E.O. Haaff, S.M. Dresner Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors J Urol 139 1988 935
5. H. Suttmann, M. Jacobsen, K. Reiss, D. Jocham, A. Bohle, S. Brandau Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation J Urol 172: 2004 1490
6. S. Brandau, A. Bohle Activation of natural killer cells by Bacillus Calmette-Guerin Eur Urol 39: 2001 518
7. S.A. Kadhim, J.L. Chin, E. Batislam, S.J. Karlik, B. Garcia, E. Skamene Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor J Urol 158 1997 646
8. S.M. Vidal, E. Pinner, P. Lepage, S. Gauthier, P. Gros Natural resistance to intracellular infections Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains J Immunol 157 1996 3559
9. R. Bellamy, C. Ruwende, T. Corrah, K.P. McAdam, H.C. Whittle, A.V. Hill Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans N Engl J Med 338 1998 640
10. J.M. Blackwell, T. Goswami, C.A. Evans, D. Sibthorpe, N. Papo, J.K. White SLC11A1 (formerly NRAMP1) and disease resistance Cell Microbiol 3 2001 773
11. J. Liu, T.M. Fujiwara, N.T. Buu, F.O. Sanchez, M. Cellier, A.J. Paradis Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene Am J Hum Genet 56 1995 845
12. C. Dombrowski, S. Levesque, M.L. Morel, P. Rouillard, K. Morgan, F. Rousseau Premutation and intermediate-size FMR1 alleles in 10572 males from the general population loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles Hum Mol Genet 11 2002 371
13. J.I. Epstein, M.B. Amin, V.R. Reuter, F.K. Mostofi The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435
14. J.M. Blackwell, S. Searle Genetic regulation of macrophage activation understanding the function of Nramp1 (=Ity/Lsh/Bcg) Immunol Lett 65 1999 73
15. E.G. Hoal, L.A. Lewis, S.E. Jamieson, F. Tanzer, M. Rossouw, T. Victor SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa Int J Tuberc Lung Dis 8 2004 1464
16. J.M. Blackwell, S. Searle, T. Goswami, E.N. Miller Understanding the multiple functions of Nramp1 Microbes Infect 2 2000 317
17. J.M. Penninger, T. Wen, E. Timms, J. Potter, V.A. Wallace, T. Matsuyama Spontaneous resistance to acute T-cell leukaemias in TCRV gamma 1.1J gamma 4C gamma 4 transgenic mice Nature 375 1995 241
18. H. Kobayashi, Y. Tanaka, J. Yagi, H. Toma, T. Uchiyama Gamma/delta T cells provide innate immunity against renal cell carcinoma Cancer Immunol Immunother 50 2001 115
19. A. Moris, S. Rothenfusser, E. Meuer, R. Hangretinger, P. Fisch Role of gammadelta T cells in tumor immunity and their control by NK receptors Microbes Infect 1 1999 227
20. Y. Kato, Y. Tanaka, F. Miyagawa, S. Yamashita, N. Minato Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens J Immunol 167: 2001 5092